Shaodong Zhai
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integrated Network Pharmacology and Experimental Validation Approach to Systematically Elucidate the Cardioprotective Mechanisms of Shengmai Injection.
Journal: Cardiovascular therapeutics
Published: October 31, 2025
Natural polysaccharide-nucleic acid nanocomplex alleviates myocardial infarction by driving chronologically programmed macrophage polarization.
Journal: Materials today. Bio
Published: October 24, 2025
Correction to [Platelet Membrane-Encapsulated Nanocomplexes Based on Profundity Scavenging ROS Strategy for Myocardial Infarction Therapy] (Adv. Healthcare Mater. 2024, 2303101).
Journal: Advanced healthcare materials
Published: October 23, 2025
Liposome-mediated macrophage reprogramming: emerging strategies for chronic disease therapy.
Journal: Frontiers in immunology
Published: June 25, 2025
Targeted delivery of calcium antagonist by side-chain selenium containing polymer for cardiac hypertrophy therapy.
Journal: Colloids and surfaces. B, Biointerfaces
Published: April 17, 2025
Circ_0049979 ameliorates myocardial infarction through improving Cx43-mediated endothelial functions.
Journal: Toxicology and applied pharmacology
Published: May 23, 2024
Enhanced-permeability delivery system for hydroxyl radical-responsive NIR-II fluorescence-monitored thrombolytic therapy.
Journal: Colloids and surfaces. B, Biointerfaces
Published: May 15, 2024
Platelet Membrane-Encapsulated Nanocomplexes Based on Profundity Scavenging ROS Strategy for Myocardial Infarction Therapy.
Journal: Advanced healthcare materials
Published: September 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026